Project Grant 2135508

Award Date 12/1/21
Completion Date 8/31/22
Dollars Obligated $268K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Kirkland, WA 98034, USA
Similar Awards
The National Science Foundation (NSF) awarded a Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Resilient Lifescience, Inc. for the development and validation of a novel wearable medical device to detect and treat opioid overdose. The $274,964 award, effective March 15, 2024 through December 31, 2024, will fund the development of two key components: 1) a self-contained, patch-based drug delivery platform capable of reliably delivering multiple...
This federal Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $649,585 to Auburn University to develop an integrated and miniaturized opioid sensor system. The project aims to address the opioid crisis through innovative, cost-efficient, and portable opioid biosensors that can enable real-time, accurate detection and monitoring. The interdisciplinary team is working to deliver solutions for law...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $591,752 to Oprems LLC to develop and evaluate a digital platform for screening patients who receive prescribed opioid medications for potential risk of opioid misuse and overdose. The key products and services to be delivered under this grant include integrating the screening tools and process developed by Oprems' existing...
The National Science Foundation (NSF) Division of Information and Intelligent Systems awarded a $162,827 Project Grant to the University of Wisconsin - Madison, through the University of Wisconsin System, to develop an "Intelligent Pervasive Augmented Reality Therapy (IPAL)" system for managing opioid use disorder (OUD) and addiction. The 1-year project will integrate complementary psychotherapies like cognitive behavioral therapy and heart rate variability biofeedback with immersive...
The National Institute on Drug Abuse (NIDA) awarded a $586,340 Project Grant (CFDA 93.279, Drug Use and Addiction Research Programs) to Tenvos Inc., a minority-owned and woman-owned small business, to develop an artificial intelligence-based technology that can remotely detect opioid use by analyzing 15 seconds of a person's speech. The project aims to further develop Tenvos' solution and understand how opioid use affects vocal characteristics, while comparing the detection method to current...
The National Institute on Drug Abuse (NIDA) awarded a $800,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Tenvos Inc., a minority-owned and woman-owned technology company. The grant will support the development of a software-based medical device (SAMD) integrated into a smartphone application that can detect opioid use through voice analysis. The proposed solution aims to enable patients in outpatient opioid use disorder (OUD) treatment to remotely test for...
This Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) provides $244,008 to The Research Foundation for the State University of New York (SUNY) to develop novel analytical methods and decision support models to help county policymakers in West Virginia more effectively combat the opioid crisis. The project aims to assess the effectiveness of interventions that disrupt opioid supply chains, including both supply-side interdiction strategies and...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $318,875 to Spark Biomedical Inc., a small disadvantaged business, to develop a machine learning algorithm for detecting opioid withdrawal symptoms and cravings. The goal is to integrate this algorithm with Spark Biomedical's transcutaneous auricular neurostimulation (TAN) device, Sparrow Ascent, to create a closed-loop system that can monitor...
This $1,500,000 Project Grant award from the National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Federal Grant Program (CFDA 47.070) is for the University of Notre Dame to develop an AI-driven paradigm to promote community resilience and prevent opioid misuse and addiction among teenagers and young adults (TYAs). The key products and services to be delivered under this 4-year grant include: 1) Using graph neural networks and self-supervised/prompt learning...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $295,906 to Addinex Technologies, Inc. to integrate and assess a closed-loop medication management system for opioid pain management in ambulatory patients with extremity fractures being discharged from the emergency department. The project aims to adapt Addinex's existing medication dispensing platform to work within a hospital pharmacy setting,...

Opos.ai, Inc. received a $267,557 Project Grant award from the National Science Foundation on December 1, 2021 to develop an opioid taper clinical decision support tool for use in primary care outpatient settings. The tool will assist primary care providers in safely tapering patients off opioid medications and is intended to address the ongoing public health crisis of opioid addiction and overdose. This award falls under the NSF's Technology, Innovation, and Partnerships program (CFDA 47.084), which seeks technology and innovation solutions to national challenges. The period of performance for this Phase I Small Business Innovation Research grant concludes on August 31, 2022, with the goal of developing a prototype opioid taper tool to help curb the epidemic.

Generated 1/7/24, 12:19 AM